Palliative experts say Ind. painkiller rules could hurt patients | Study compares survival, quality of life with kidney cancer drugs | Wellness services can help launch palliative programs
Web Version
August 29, 2013
CONNECT WITH LIVESTRONG  FacebookTwitterPinterestFlickrYouTube
Cancer news and resources for health care professionals

Patient-Centered Cancer CareSponsored By
Palliative experts say Ind. painkiller rules could hurt patients
The Indiana Medical Licensing Board is considering guidelines to reduce the abuse of painkillers that would add requirements for physicians who prescribe the drugs and patients who take them. Palliative care experts cautioned that while the rules would exempt patients with terminal illness, they could make it less likely for patients who live with cancer or who have chronic pain to get appropriate treatment. The Indianapolis Star (tiered subscription model) (8/21)
Share: LinkedIn Twitter Facebook Google+ Email
Study compares survival, quality of life with kidney cancer drugs
Survival times for patients with advanced kidney cancer were comparable with either pazopanib or sunitinib, but pazopanib was linked to milder side effects and better quality of life, according to a study in the New England Journal of Medicine. GlaxoSmithKline, which makes pazopanib, paid for the head-to-head comparison. HealthDay News (8/22)
Share: LinkedIn Twitter Facebook Google+ Email
Other News
Join Team LIVESTRONG in 2013
Team LIVESTRONG walks, runs, rides, swims, volunteers and fundraises in events around the U.S. Funds raised by these events support free programs and resources for cancer survivors. Our team changes the way the world fights cancer. Join us at
Emerging Trends, Products & Technologies
Company seeks to test, launch wireless breast self-examination tool
Eclipse Breast Health Technologies is trying to raise funds for the testing and launch of its wireless system designed for the early detection of breast cancer. The system, which leverages "transphotonic" technology, consists of imaging software and a hand-held device that monitors breast density changes. The wireless breast self-exam device also allows users to upload their data on the Pink Cloud platform and share it with their providers. (8/22)
Share: LinkedIn Twitter Facebook Google+ Email
Cancer Research & Health Policy
Blood test and ultrasound evaluation improves ovarian cancer detection
Using a blood tumor marker called CA125 to determine a woman's risk for ovarian cancer, in conjunction with trans-vaginal ultrasound, can help identify the cancer earlier, when it's more amenable to treatment. In an 11-year study of 4,051 post-menopausal women, 10 underwent surgery following trans-vaginal ultrasound exams that yielded suspicious results, and seven were found to have cancer. All seven were then treated successfully for the disease, according to findings published in the journal Cancer. The Economic Times (India)/Press Trust of India (8/26), HealthDay News (8/26)
Share: LinkedIn Twitter Facebook Google+ Email
Study: Decitabine may halt breast cancer metastasis
Data from lab and animal research revealed that the blood cancer drug decitabine may help stop breast cancer metastasis by activating a gene coding for protein kinase D1. The results appear in the journal Breast Cancer Research. Business Standard (India)/Asian News International (8/26)
Share: LinkedIn Twitter Facebook Google+ Email
Follow-up report confirms benefits of finasteride therapy
A New England Journal of Medicine report said follow-up data from a study of finasteride that ended in 2003 showed it can reduce the overall risk of prostate cancer in men who were regularly screened for the disease. The study update confirmed results of the Prostate Cancer Prevention Trial and found that an increased risk of high-grade cancer associated with use of the drug did not have an effect on mortality. AAFP News Now (8/23)
Share: LinkedIn Twitter Facebook Google+ Email
Other News
Foundation News
Who we are: the LIVESTRONG Foundation
The heart and soul of the Foundation is the people. Our staff hosts events, creates and evaluates programs, offers direct support to anyone affected and so much more. Many of us are survivors. Most of us have supported a loved one with cancer. All of us are dedicated to serving those in the fight right now. Learn more about who we are.
Share: LinkedIn Twitter Facebook Google+ Email
IPad Cancer Guide and Tracker App
At the LIVESTRONG Foundation, we believe that everyone should have the information and tools they need to make informed decisions throughout their cancer journey. That's why we introduced the free LIVESTRONG Cancer Guide and Tracker iPad App, which lets users store and access information relevant to treatment and survivorship electronically. The Cancer Guide shares information on what to expect, what questions to ask and provides helpful resources. Learn more.
Share: LinkedIn Twitter Facebook Google+ Email
I think it is very important for all of us to be aware of ways to go forward with making ourselves feel comfortable with our bodies again."
-- Ann F., cancer survivor
Share: LinkedIn Twitter Facebook Google+ Email
Learn more about LIVESTRONG ->Homepage
The LIVESTRONG Foundation does not necessarily endorse the opinions that may be mentioned on this site, the articles are published for informational purposes and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this site.
About the LIVESTRONG Foundation
The LIVESTRONG Foundation provides free cancer support services to help people cope with the financial, emotional and practical challenges that accompany the disease. Created in 1997 by cancer survivor and philanthropist Lance Armstrong, the Foundation is known for its powerful brand – LIVESTRONG–and for its advocacy on behalf of survivors and their families. With its iconic yellow LIVESTRONG wristband, the Foundation has become a symbol of hope and inspiration around the world. Since its inception, the Foundation has raised nearly $500 million to support cancer survivors and served 2.5 million people affected by the disease. For more information, visit
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Lead Editor:  Kathryn Doherty

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.®
Privacy policy |  Legal Information